NG25

News alerts, weekly reports and conference planners

Company:

Dana-Farber Cancer Institute, Harvard Medical School

Drug class:

TAK1 inhibitor

Related drugs:

‹

›

KRAS mutation	Colorectal Cancer	KRAS mutation	Colorectal Cancer	NG25 Sensitive: D – Preclinical NG25 Sensitive : D	NG25 Sensitive: D – Preclinical NG25 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	NG25 Sensitive: D – Preclinical NG25 Sensitive : D	NG25 Sensitive: D – Preclinical NG25 Sensitive : D

Associations
(2)